Literature DB >> 3960424

Incidence and recurrence rate of abruptio placentae in Sweden.

M Kåregård, G Gennser.   

Abstract

It is desirable to identify those pregnancies that run an increased risk of abruptio placentae, as this disorder still is associated with a high perinatal mortality. Data were collected from the Swedish nationwide birth registry system on all 894,619 births in Sweden in the period 1973 to 1981. The overall incidence of abruptio placentae was 0.44%, with a perinatal mortality of 20.2% and a cesarean section frequency of 74.6%. The incidence of abruptio placentae was significantly increased in the case of twin birth, male offspring, mothers below 20 years of age, and with every delivery after the second one. A history of abruptio placentae increased the risk of a similar incident in a subsequent pregnancy by 10.2-fold. The frequency of cesarean section in subsequent parturitions remained high (32.1%) even in the absence of reabruptio placentae, thus demonstrating the need to identify further risk groups.

Mesh:

Year:  1986        PMID: 3960424

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

1.  Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption.

Authors:  Cande V Ananth; Denise A Elsasser; Wendy L Kinzler; Morgan R Peltier; Darios Getahun; Daniel Leclerc; Rima R Rozen
Journal:  Mol Genet Metab       Date:  2007-03-26       Impact factor: 4.797

2.  The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD).

Authors:  Sun Kwon Kim; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Pooja Mittal; Tinnakorn Chaiworapongsa; Percy Pacora; Giovanna Oggé; Ricardo Gomez; Bo Hyun Yoon; Lami Yeo; Ronald F Lamont; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010       Impact factor: 1.901

3.  Placental Histopathology and Pregnancy Outcomes in "Early" vs. "Late" Placental Abruption.

Authors:  Noa Gonen; Michal Levy; Michal Kovo; Letizia Schreiber; Lilach Kornblit Noy; Eldar Volpert; Jacob Bar; Eran Weiner
Journal:  Reprod Sci       Date:  2020-08-18       Impact factor: 3.060

4.  Associations between 2 polymorphisms in the methylenetetrahydrofolate reductase gene and placental abruption.

Authors:  Cande V Ananth; Morgan R Peltier; Celeste De Marco; Denise A Elsasser; Darios Getahun; Rima Rozen; John C Smulian
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

Review 5.  Interventions for treating placental abruption.

Authors:  J P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2003

6.  Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden.

Authors:  Lisa DeRoo; Rolv Skjærven; Allen Wilcox; Kari Klungsøyr; Anna-Karin Wikström; Nils-Halvdan Morken; Sven Cnattingius
Journal:  Eur J Epidemiol       Date:  2015-07-16       Impact factor: 8.082

7.  An international contrast of rates of placental abruption: an age-period-cohort analysis.

Authors:  Cande V Ananth; Katherine M Keyes; Ava Hamilton; Mika Gissler; Chunsen Wu; Shiliang Liu; Miguel Angel Luque-Fernandez; Rolv Skjærven; Michelle A Williams; Minna Tikkanen; Sven Cnattingius
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

8.  Pharmacological treatment for pregnant women who smoke cigarettes.

Authors:  Bc Chan; G Koren
Journal:  Tob Induc Dis       Date:  2003-09-15       Impact factor: 2.600

9.  A population-based study of race-specific risk for placental abruption.

Authors:  Tammy T Shen; Emily A DeFranco; David M Stamilio; Jen Jen Chang; Louis J Muglia
Journal:  BMC Pregnancy Childbirth       Date:  2008-09-12       Impact factor: 3.007

10.  Incidence and outcome of severe ante-partum hemorrhage at the Teaching Hospital Yalgado Ouédraogo in Burkina Faso.

Authors:  Martin Lankoande; Papougnezambo Bonkoungou; Sosthène Ouandaogo; Marcelin Dayamba; Ali Ouedraogo; Francis Veyckmans; Nazinigouba Ouédraogo
Journal:  BMC Emerg Med       Date:  2017-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.